The global Virus Filtration Market size is expected to reach
USD 7.0 billion by 2026, according to a new report by Grand View Research, Inc.
It is anticipated to register a CAGR of 12.7% during the forecast period.
Increasing demand for biological products such as vaccines, therapeutic
proteins, blood and blood products, cellular and gene therapy, tissue, and stem
cell products is a major factor driving the growth. Biopharmaceuticals are
mainly derived from human, animal, and plants and therefore require a
scrutinized virus filtration procedure to avoid virus contamination in the
production. Therefore, the necessity of this procedure during the production of
biologics is expected to boost the market growth.
Many leading biopharmaceuticals and biotechnology
manufacturers are involved in R&D to develop innovative biological
products. For instance, in 2016, Pfizer Inc. invested USD 7,872.0 million in
R&D, which was around 8% more than the R&D investment in 2015. This
investment was mainly made to boost innovation and productivity in R&D to
accomplish a sustainable pipeline of vaccines and differentiated therapies with
lucrative commercial opportunities. Virus filtration is an important step in
biologics development, thus, increasing R&D on biologics is expected to
drive the product demand.
To request a sample copy or view summary of this report,
click the link below:
https://www.grandviewresearch.com/industry-analysis/virus-filtration-market
https://www.grandviewresearch.com/industry-analysis/virus-filtration-market
Further key findings from the report suggest:
- Consumables
was the largest revenue generating segment in 2018 owing to the increased
usage of consumables including reagents, kits, and membranes in biologics
downstream processing
- Chromatography
technology segment is projected to expand at the fastest CAGR during the
forecast period, owing to advancements such as disposable or single-use
membranes that eliminate the risk of a potential virus contaminant
- Biologicals
segment held the largest market share in 2018 and is projected to maintain
its dominance during the forecast period due to rising prevalence of
chronic diseases such as cancer, blood disorders, and diabetes
- The
biotechnology and biopharmaceutical companies segment is projected to
expand at the fastest CAGR over the forecast period owing to increasing
investment in R&D and production of biologics
- North
America led the virus filtration market in 2018 primarily due to the
presence of several leading biotechnology companies and increased R&D
activities
- Asia Pacific
is estimated to expand at the highest CAGR during the forecast period.
Growing presence of CROs in countries including China and India due to the
presence of a large genome pool, less stringent regulations, and
availability of economical labor force is contributing to the regional
growth
- Some of the
major players are Merck KGaA; Sartorius; Danaher; Thermo Fisher
Scientific, Inc.; Charles River Laboratories International, Inc.; GE
Healthcare; Asahi Kasei Medical Co., Ltd.; WuXi PharmaTech (Cayman) Inc.;
Lonza; and Clean Cells
Grand View Research has segmented the global virus filtration
market on the basis of product, technology, application, end use, and region:
Virus Filtration Product Outlook (Revenue, USD Million,
2015 - 2026)
- Consumables
- Kits and
reagents
- Others
- Instruments
- Filtration
systems
- Chromatography
systems
- Services
Virus Filtration Technology Outlook (Revenue, USD
Million, 2015 - 2026)
- Filtration
- Consumables
- Instruments
- Services
- Chromatography
- Consumables
- Instruments
- Services
Virus Filtration Application Outlook (Revenue, USD
Million, 2015 - 2026)
- Biologicals
- Vaccines
and therapeutics
- Blood and
blood products
- Cellular
and gene therapy products
- Tissue and
tissue products
- Stem cell
products
- Medical
devices
- Water
purification
- Air
purification
Virus Filtration End Use Outlook (Revenue, USD
Million, 2015 - 2026)
- Biopharmaceutical
& biotechnology companies
- Contract
research organizations
- Medical
devices companies
- Academic
institutes & research laboratories
Virus Filtration Regional Outlook (Revenue, USD
Million, 2015 - 2026)
- North
America
- U.S.
- Canada
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Asia Pacific
- Japan
- China
- India
- South
Korea
- Australia
- Singapore
- Latin
America
- Brazil
- Mexico
- Argentina
- MEA
- South
Africa
- Saudi
Arabia
- UAE
About Us:
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com
Blog: https://healthcareforecastreport.blogspot.com/
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com
Blog: https://healthcareforecastreport.blogspot.com/
No comments:
Post a Comment